-
Honeybee Smo Signaling and Olfactory Function
2026-08-27
Guo and colleagues identify and functionally characterize Smoothened (Smo) in Apis mellifera, showing that pharmacological pathway perturbation changes Smo and olfactory receptor expression as well as odor-related electrophysiological and behavioral responses. The study provides a cross-level framework for examining Hedgehog signaling in insect sensory biology while highlighting the limits of inferring direct molecular causality from pharmacological experiments.
-
Partial BACE Inhibition and Synaptic Transmission
2026-08-27
Satir et al. examined whether partial BACE inhibition can lower amyloid-beta secretion without disrupting neuronal function. Using primary rat cortical cultures and optical electrophysiology, they found that reductions below 50% preserved synaptic transmission, whereas stronger inhibition impaired it, defining a potentially important exposure window for Alzheimer’s disease research.
-
CHI3L1-IN-5: Astrocyte Aβ Clearance Workflow
2026-08-26
CHI3L1-IN-5 (Compound Z17) provides a practical way to connect inflammatory signaling with defective amyloid handling in human astrocyte assays. This workflow combines CHI3L1 challenge, NF-κB pathway monitoring, Aβ uptake restoration, and lysosomal function repair in astrocytes to produce a more informative translational data package.
-
LAMP1 Controls CXCR3-Linked Macrophage Polarization
2026-08-26
The 2024 International Immunopharmacology study identifies LAMP1 as a state-dependent switch linking the CXCL10-CXCR3 axis to macrophage polarization. Its combination of pharmacological antagonism, LAMP1 knockdown, autophagy readouts, and a poly(I:C)-induced lung injury model provides a framework for interpreting CXCR3 signaling in inflammatory and non-inflammatory contexts.
-
Erlotinib, EGFR, and SCUBE3 in Translational Oncology
2026-08-25
Erlotinib, also known as NSC 718781, offers a precise way to interrogate EGFR dependence while emerging SCUBE3 biology reframes how researchers study oncogenic signaling, therapy resistance, and immune suppression. This thought-leadership guide connects mechanism, assay design, and translational strategy for more informative preclinical models.
-
Methoxy-X04 Workflows for Amyloid Imaging
2026-08-25
Methoxy-X04 converts amyloid pathology into a measurable fluorescence readout for in vivo and tissue-based Alzheimer’s disease experiments. This workflow connects plaque and cerebrovascular amyloid visualization with rTMS studies of microglial clearance, while emphasizing controls, timing, and reproducibility.
-
FPS-ZM1: RAGE Inhibitor Workflow for Brain Studies
2026-08-24
Use FPS-ZM1 to separate RAGE-dependent amyloid beta transport, neuronal stress, and neuroinflammation from broader metabolic effects. This practical workflow connects Aβ40/Aβ42 challenge models with the RAGE/POMC findings reported in hypothalamic research while preserving clear translational limits.
-
FPS-ZM1: Reframing RAGE for Translational Research
2026-08-24
A mechanistic and strategic guide to using FPS-ZM1 as a selective RAGE inhibitor across amyloid beta signaling, neuroinflammation, and emerging RAGE/POMC research.
-
Capsaicin as a KDM1A/LSD1 Inhibitor
2026-08-23
The 2020 study identified Capsaicin as a reversible, FAD-competitive inhibitor of lysine-specific demethylase 1A (KDM1A/LSD1), with direct biochemical binding and activity in gastric cancer cells. Its findings connect a familiar TRPV1-active natural product with histone methylation control, cell migration, invasion, and epithelial–mesenchymal transition, while also highlighting important questions about selectivity and translational relevance.
-
Smo in Honeybees: Olfactory Roles of Hedgehog
2026-08-22
Guo et al. characterized Smoothened (Smo) in Apis mellifera and linked pharmacological pathway perturbation to olfactory receptor expression, electroantennography, and odor-guided behavior. The study provides a cross-level framework for investigating Hedgehog signaling in insect sensory biology while highlighting the need to separate molecular association from direct pathway activation.
-
Intravesical p21 mRNA–LNP Therapy in Bladder Cancer
2026-08-22
The reference study develops chemically modified p21 mRNA encapsulated in lipid nanoparticles for localized intravesical treatment of bladder cancer. Its findings connect bladder-restricted protein expression with tumor-suppressor restoration, reduced cell-cycle activity, DNA-damage signaling, and tumor growth suppression in an orthotopic mouse model.
-
2,2,2-Trichloroethanol: From Gels to Translation
2026-08-21
A translational perspective on 2,2,2-Trichloroethanol as a protein analysis reagent, connecting gel-based molecular quality control with the longitudinal imaging and histological evidence needed to evaluate dopaminergic cell therapies.
-
(5Z)-7-Oxozeaenol: A TAK1 Inhibitor Workflow
2026-08-20
Use (5Z)-7-Oxozeaenol to resolve how TAK1 connects IL-1-driven inflammation with NF-κB, JNK/p38 MAPK, and metabolic-stress signaling. This practical guide covers dosing, pathway readouts, washout experiments, and troubleshooting for cell-based and inflammation-model studies.
-
DiI (DiIC18(3)) Membrane Probe Guide
2026-08-20
DiI (DiIC18(3)) provides orange-red plasma membrane labeling for live or fixed cells and tissues, supporting membrane tracking, neuronal tracing, migration, adhesion, and lipoprotein studies. It requires an organic-solvent stock and is not appropriate for aqueous-only staining or selective labeling of intracellular organelles.
-
Amphotericin B Workflows for Fungal Research
2026-08-19
Build more reliable antifungal, biofilm, immune-signaling, and sterol-mechanism assays with Amphotericin B. This guide translates membrane biology and recent ergosterol-sensitization findings into practical preparation, dosing, comparison, and troubleshooting strategies.